title: [Treatment of diarrhea with loperamide in palliative medicine. A systematic review].
abstract: Diarrhea is a distressing symptom which limits the quality of life in patients receiving palliative care and is associated with high morbidity and mortality. In patients with AIDS, it is a more common problem than for other entities (e.g., cancer). Loperamide is considered the first choice medication for the symptomatic treatment of diarrhea. This literature review examines the efficacy of loperamide in the symptomatic treatment of diarrhea in palliative care. Two databases (Medline and Embase) were searched through June 2012. A total of 286 studies were identified, but only 7 met the inclusion criteria (1 cohort and 6 experimental studies) in which loperamide (alone or in combination) was tested. There is a lack of significant studies which investigate the efficacy of loperamide in the symptomatic treatment of diarrhea. Two trials indicated superiority of loperamide over placebo. In comparison with octreotide, the results were contradictory. The combination of acetorphan with loperamide was more effective than acetorphan alone, but the combination of loperamide with diphenoxylate was inferior to octreotide. The identified studies revealed methodical problems. A definite recommendation for administration of loperamide can, therefore, not be derived from this work.The English full-text version of this article is available at SpringerLink (under "Supplemental").
authors.affiliation: Klinik für Palliativmedizin, Universitätsklinikum Aachen, RWTH Aachen, Pauwelsstrasse 30, Aachen, Germany. tpastrana@ukaachen.de
authors.forename: T
authors.initials: T
authors.lastname: Pastrana
authors.forename: W
authors.initials: W
authors.lastname: Meißner
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000930:Antidiarrheals / Q000009:adverse effects / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D004157:Diphenoxylate / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008139:Loperamide / Q000009:adverse effects / Q000627:therapeutic use*; D015282:Octreotide / Q000009:adverse effects / Q000627:therapeutic use; D010166:Palliative Care; D015244:Thiorphan / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000930:Antidiarrheals; D008139:Loperamide; D004157:Diphenoxylate; C049331:racecadotril; D015244:Thiorphan; D015282:Octreotide